Medartis Holding AGXSWX:MED +7.08%76 Pretax Margin % is 8.37% as of Dec. 2025, which is 272% above its 10-year median of 2.25. GuruFocus rates XSWX:MED with a GF Score™ of 76/100 and a GF Value™ of CHF105.66 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Medartis Holding AG ranks better than 54.35% on this metric.
The historical rank and industry rank for Medartis Holding AG's Pretax Margin % or its related term are showing as below:
XSWX:MED'
s Pretax Margin % Range Over the Past 10 Years
Min: -3.91 Med: 2.25 Max: 7.66
Current: 4.75
XSWX:MED's Pretax Margin % is ranked better than 54.35% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.61
vs XSWX:MED: 4.75
Medartis Holding AG (XSWX:MED) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Medartis Holding AG Pretax Margin % Related Terms
Medartis Holding AG Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Medartis Holding AG's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:MED vs ABT, SYK, MDT: Pretax Margin % Comparison
For the Medical Devices subindustry, Medartis Holding AG's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medartis Holding AG Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medartis Holding AG's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Medartis Holding AG's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medartis Holding AG (XSWX:MED) has a Pretax Margin % of 8.37% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Medartis Holding AG and its competitors. This is 272% above median its historical median of 2.25. According to the industry distribution chart, Medartis Holding AG ranks #373 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 45.7%.
Is Medartis Holding AG's Pretax Margin % too high?
Medartis Holding AG's current Pretax Margin % of 8.37% is 272% above median its 10-year median of 2.25. The Medical Devices & Instruments industry median Pretax Margin % is 2.61. Medartis Holding AG's value of 8.37% is 220.7% above this industry median. Based on the distribution chart, Medartis Holding AG ranks #373 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Medartis Holding AG has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medartis Holding AG's Pretax Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medartis Holding AG ranks #373 out of 817 companies for Pretax Margin %. This puts Medartis Holding AG in the upper half of its industry. The industry median Pretax Margin % is 2.61. Medartis Holding AG's value of 8.37% is 220.7% above this benchmark. While the company's 10-year median is 2.25 vs. the industry median of 2.61, Medartis Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.61, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medartis Holding AG's current Pretax Margin % of 8.37% is 220.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Medartis Holding AG and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medartis Holding AG's current Pretax Margin % is 8.37%, which is 272% above median its own 10-year median of 2.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medartis Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Medartis Holding AG (XSWX:MED) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF105.66, compared to a current price of CHF77.10 — trading 27% below its estimated fair value. The current Pretax Margin % is 8.37%, which is 272% above median its 10-year median of 2.25 and 220.7% above the Medical Devices & Instruments industry median of 2.61. Medartis Holding AG's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Medartis Holding AG (XSWX:MED), the current Pretax Margin % is 8.37% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medartis Holding AG (XSWX:MED) Overvalued in 2026?
Based on GuruFocus' analysis, Medartis Holding AG stock appears to be undervalued.
The current stock price of CHF77.10 is trading 27% below its estimated GF Value™ of CHF105.66.
GuruFocus considers Medartis Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:MED:
Pretax Margin %: 8.37% (272% above median its 10-year median of 2.25)
GF Value™: CHF105.66 vs. price of CHF77.10 (27% below fair value)
Industry Position: 220.7% above the Medical Devices & Instruments median (#373 of 817)
No single metric tells the full story. See the XSWX:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for the Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from Europe, Middle East and Africa (EMEA) and also has a presence in North America, Asia Pacific, and Latin America.
76GF Score
Get the complete analysis for XSWX:MED
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:MED has been successfully added to your 
